These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4261530)

  • 41. [Psychic manifestations during treatment of Parkinson's disease with L-dopa].
    Bonduelle M
    Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897
    [No Abstract]   [Full Text] [Related]  

  • 42. [L-DOPA administration in parkinsonism].
    Narabayashi H; Kosaka K
    Naika; 1971; 28(3):436-9. PubMed ID: 5097704
    [No Abstract]   [Full Text] [Related]  

  • 43. [L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease].
    Lakke JP; Nienhuis RJ; Meyer R; Zwols F; Schut T
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2180-4. PubMed ID: 4639072
    [No Abstract]   [Full Text] [Related]  

  • 44. [Collateral effects of therapy with L-dopa in Parkinson's disease].
    Gomirato G; Perfetti CC; Ecari U
    Sist Nerv; 1970; 22(2):67-73. PubMed ID: 5504559
    [No Abstract]   [Full Text] [Related]  

  • 45. [L-dopa therapy in Parkinsonian syndromes].
    Policlinico Prat; 1970 Sep; 77(36):1156-61. PubMed ID: 5495548
    [No Abstract]   [Full Text] [Related]  

  • 46. [L-DOPA therapy in patients with parkinsonism].
    Stam FC; Heslinga FJ
    Ned Tijdschr Geneeskd; 1970 May; 114(20):849-52. PubMed ID: 5446181
    [No Abstract]   [Full Text] [Related]  

  • 47. [One year of experience with L-Dopa in Parkinson's disease].
    Henry P; Lacut JY; Pouget-Abadie J; Bergouignan M; Leng-Lĕvy J
    Bord Med; 1971 May; 4(5):1581-91. PubMed ID: 5569952
    [No Abstract]   [Full Text] [Related]  

  • 48. Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
    Sacks OW; Ross SJ; DePaola DP; Kohl MS
    Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661
    [No Abstract]   [Full Text] [Related]  

  • 49. [L-dopa in the treatment of parkinsonism].
    Goldsztajn M; Reichowa J
    Przegl Lek; 1971 Sep; 27(9):592-3. PubMed ID: 4942580
    [No Abstract]   [Full Text] [Related]  

  • 50. Involuntary movements in chorea-acanthocytosis: a comparison with Huntington's chorea.
    Shibasaki H; Sakai T; Nishimura H; Sato Y; Goto I; Kuroiwa Y
    Ann Neurol; 1982 Sep; 12(3):311-4. PubMed ID: 6215892
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of parkinsonian states with L-dopa].
    Boudin G; Guillard A; Pépin B
    Bull Acad Natl Med; 1971 Nov; 155(28):707-12. PubMed ID: 4948142
    [No Abstract]   [Full Text] [Related]  

  • 52. [L-Dopa in parkinsonism, myth or reality].
    Henry P
    Bord Med; 1970 Feb; 3(2):393-7. PubMed ID: 5425873
    [No Abstract]   [Full Text] [Related]  

  • 53. An evaluation of L-dopa in Parkinson patients.
    Mones RJ
    Trans Am Neurol Assoc; 1969; 94():307-9. PubMed ID: 5374472
    [No Abstract]   [Full Text] [Related]  

  • 54. L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients).
    Fincham RW; Decker DA
    J Iowa Med Soc; 1970 Nov; 60(11):755-9. PubMed ID: 5482403
    [No Abstract]   [Full Text] [Related]  

  • 55. [Parkinson's syndrome. 7. Experiences with L-dopa-treatment].
    Svanborg A
    Lakartidningen; 1970 Oct; 67(42):4827-31. PubMed ID: 5478708
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of L-dopa therapy in Parkinson's disease.
    Thompson RA; White JC; Echols CL
    Ariz Med; 1970 Jul; 27(7):5-10. PubMed ID: 5432717
    [No Abstract]   [Full Text] [Related]  

  • 57. Failures of L-dopa.
    Paulson GW
    Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
    [No Abstract]   [Full Text] [Related]  

  • 58. [Disorders of nocturnal sleep in Huntington chorea].
    Iakhno NN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):340-6. PubMed ID: 2986395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of parkinsonism with L-dopa].
    Court J; Kase JC; Palacios E; Mena I
    Rev Med Chil; 1971 Jun; 99(6):399-401. PubMed ID: 5561157
    [No Abstract]   [Full Text] [Related]  

  • 60. L-dopa in the treatment of Parkinsonism.
    Brezný I; Buranová D; Cernácek J; Trávniková M
    Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.